Wird geladen...
Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia
Purpose: To determine the efficacy and safety of topical bevacizumab treatment in patients with ocular surface squamous neoplasia (OSSN). Methods: Six eyes of 6 patients with primary OSSN confirmed by impression cytology received topical 5 mg/mL bevacizumab 4 times daily for a period of 8 weeks. Pat...
Gespeichert in:
| Veröffentlicht in: | J Ocul Pharmacol Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Mary Ann Liebert, Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599122/ https://ncbi.nlm.nih.gov/pubmed/26114378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2014.0158 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|